Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WM-115 | Vemurafenib | Defactinib | 0.100 | 3.160 | uM | 72 | hr | 3 | 1995 | 254 | 0.4161 | 0.4208 | 0.1273 | 0.1284 |
WM-115 | Vemurafenib | Defactinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 1905 | 223 | 0.4020 | 0.4208 | 0.1171 | 0.1284 |
WM-115 | Vemurafenib | Defactinib | 0.100 | 3.160 | uM | 72 | hr | 1 | 2164 | 305 | 0.4443 | 0.4208 | 0.1409 | 0.1284 |
WM-115 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 1 | 2506 | 243 | 0.5885 | 0.5553 | 0.0970 | 0.0985 |
WM-115 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 2322 | 246 | 0.5398 | 0.5553 | 0.1059 | 0.0985 |
WM-115 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 3 | 2278 | 211 | 0.5375 | 0.5553 | 0.0926 | 0.0985 |
WM-115 | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 1 | 2173 | 305 | 0.4857 | 0.4743 | 0.1404 | 0.1338 |
WM-115 | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 2 | 2061 | 274 | 0.4647 | 0.4743 | 0.1329 | 0.1338 |
WM-115 | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 3 | 2084 | 267 | 0.4725 | 0.4743 | 0.1281 | 0.1338 |
WM-115 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 1912 | 153 | 0.4204 | 0.4405 | 0.0800 | 0.0768 |
WM-115 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 2 | 1877 | 148 | 0.4133 | 0.4405 | 0.0788 | 0.0768 |
WM-115 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 1 | 2198 | 157 | 0.4878 | 0.4405 | 0.0714 | 0.0768 |
A-375 | Vemurafenib | JNK-IN-8 | 0.316 | 3.160 | uM | 72 | hr | 3 | 1928 | 244 | 0.1059 | 0.1134 | 0.1266 | 0.1152 |
A-375 | Vemurafenib | JNK-IN-8 | 0.316 | 3.160 | uM | 72 | hr | 2 | 2210 | 240 | 0.1239 | 0.1134 | 0.1086 | 0.1152 |
A-375 | Vemurafenib | JNK-IN-8 | 0.316 | 3.160 | uM | 72 | hr | 1 | 1972 | 218 | 0.1103 | 0.1134 | 0.1105 | 0.1152 |
WM-115 | Vemurafenib | Saracatinib | 1.000 | 3.160 | uM | 72 | hr | 1 | 1760 | 362 | 0.3635 | 0.3608 | 0.2057 | 0.1852 |
WM-115 | Vemurafenib | Saracatinib | 1.000 | 3.160 | uM | 72 | hr | 2 | 1740 | 336 | 0.3651 | 0.3608 | 0.1931 | 0.1852 |
WM-115 | Vemurafenib | Saracatinib | 1.000 | 3.160 | uM | 72 | hr | 3 | 1614 | 253 | 0.3539 | 0.3608 | 0.1568 | 0.1852 |
WM-115 | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 1 | 1354 | 459 | 0.2327 | 0.2251 | 0.3390 | 0.3147 |
WM-115 | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 1196 | 350 | 0.2200 | 0.2251 | 0.2926 | 0.3147 |
WM-115 | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 3 | 1245 | 389 | 0.2226 | 0.2251 | 0.3124 | 0.3147 |
WM-115 | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 3 | 941 | 527 | 0.1033 | 0.1103 | 0.5600 | 0.5337 |
WM-115 | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 975 | 559 | 0.1038 | 0.1103 | 0.5733 | 0.5337 |
WM-115 | Vemurafenib | Dasatinib | 3.160 | 3.160 | uM | 72 | hr | 1 | 930 | 435 | 0.1236 | 0.1103 | 0.4677 | 0.5337 |
MMAC-SF | Vemurafenib | Dasatinib | 0.000 | 3.160 | uM | 72 | hr | 1 | 1338 | 86 | 0.9589 | 0.7322 | 0.0643 | 0.0524 |